T cell activation and anti-tumor efficacy of anti-LAG-3 antibodies is independent of LAG-3 – MHCII blocking capacity
Saso Cemerski, Shuxia Zhao, Melissa Chenard, Jason Laskey, Long Cui, Rinkan Shukla, Brian Haines, Edward Hsieh, Maribel Beaumont, Jeanine Mattson, Wendy Blumenschein, Heather Hirsch, Laurence Fayadat-Dilman, Linda Liang, Rene De Waal Malefyt
Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P183; DOI: 10.1186/2051-1426-3-S2-P183
